BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36438275)

  • 1. Investigation of small lung lesion detection for lung cancer screening in low dose FDG PET imaging by deep neural networks.
    Guo H; Wu J; Xie Z; Tham IWK; Zhou L; Yan J
    Front Public Health; 2022; 10():1047714. PubMed ID: 36438275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Accuracy and Lesion Detectability of Low-Dose
    Schaefferkoetter JD; Yan J; Sjöholm T; Townsend DW; Conti M; Tam JK; Soo RA; Tham I
    J Nucl Med; 2017 Mar; 58(3):399-405. PubMed ID: 27688481
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
    Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance Evaluation of a Deep Learning System for Differential Diagnosis of Lung Cancer With Conventional CT and FDG PET/CT Using Transfer Learning and Metadata.
    Park YJ; Choi D; Choi JY; Hyun SH
    Clin Nucl Med; 2021 Aug; 46(8):635-640. PubMed ID: 33883488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial results.
    Schwyzer M; Ferraro DA; Muehlematter UJ; Curioni-Fontecedro A; Huellner MW; von Schulthess GK; Kaufmann PA; Burger IA; Messerli M
    Lung Cancer; 2018 Dec; 126():170-173. PubMed ID: 30527183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
    O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
    J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the detection of small lesions using a state-of-the-art time-of-flight PET/CT system and small-voxel reconstructions.
    Koopman D; van Dalen JA; Lagerweij MC; Arkies H; de Boer J; Oostdijk AH; Slump CH; Jager PL
    J Nucl Med Technol; 2015 Mar; 43(1):21-7. PubMed ID: 25613334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial assessment of image quality for low-dose PET: evaluation of lesion detectability.
    Schaefferkoetter JD; Yan J; Townsend DW; Conti M
    Phys Med Biol; 2015 Jul; 60(14):5543-56. PubMed ID: 26134119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.
    Huang B; Sollee J; Luo YH; Reddy A; Zhong Z; Wu J; Mammarappallil J; Healey T; Cheng G; Azzoli C; Korogodsky D; Zhang P; Feng X; Li J; Yang L; Jiao Z; Bai HX
    EBioMedicine; 2022 Aug; 82():104127. PubMed ID: 35810561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
    Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Wetter A; Umutlu L; Antoch G; Heusch P
    J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study on lung cancer detection based on regional metabolic activity distribution in digital low-dose 18F-FDG PET.
    Messerli M; Muehlematter UJ; Fassbind S; Franzen D; Ferraro DA; Huellner MW; Treyer V; Curioni-Fontecedro A; Burger IA
    Br J Radiol; 2021 Mar; 94(1119):20200244. PubMed ID: 33529052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A method to assess image quality for Low-dose PET: analysis of SNR, CNR, bias and image noise.
    Yan J; Schaefferkoette J; Conti M; Townsend D
    Cancer Imaging; 2016 Aug; 16(1):26. PubMed ID: 27565136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
    Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
    AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid PET/MRI in non-small cell lung cancer (NSCLC) and lung nodules-a literature review.
    Dahlsgaard-Wallenius SE; Hildebrandt MG; Johansen A; Vilstrup MH; Petersen H; Gerke O; Høilund-Carlsen PF; Morsing A; Andersen TL
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):584-591. PubMed ID: 32719914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy.
    Conrad GR; Sinha P
    Nucl Med Commun; 2003 Nov; 24(11):1129-37. PubMed ID: 14569166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules.
    Paez R; Shah C; Cords AJ; Muterspaugh A; Helton JE; Antic S; Eisenberg R; Chen H; Grogan EL; Manning HC; Walker RC; Massion PP
    PLoS One; 2022; 17(3):e0265427. PubMed ID: 35294486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation Between Malignant and Benign Pulmonary Nodules by Using Automated Three-Dimensional High-Resolution Representation Learning With Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography.
    Lai YC; Wu KC; Tseng NC; Chen YJ; Chang CJ; Yen KY; Kao CH
    Front Med (Lausanne); 2022; 9():773041. PubMed ID: 35372415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.